Don't Jump to a CGRP Antagonist for Migraine Prophylaxis

December 2018

You'll see two new biologics to PREVENT migraine in adults, Ajovy (uh-JOH-vee, fremanezumab) and Emgality (em-GAL-ih-tee, galcanezumab).

They'll join Aimovig (erenumab)...the first calcitonin gene-related peptide blocker, or CGRP antagonist. Blocking CGRP limits vasodilation.

All are once-monthly, self-administered subcutaneous injections...or Ajovy can be given as 3 injections once every 3 months. Aimovig is an auto-injector...Ajovy is a prefilled syringe...Emgality is a pen.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

12 issues every year, with brief articles about new meds and guidelines
48+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Influenza Compare Xofluza to Tamiflu for Treating the Flu
Depression Weigh Antidepressant Options for Older Patients
Vaccines Consider Whether Gardasil 9 May Benefit Patients Over Age 26
Antithrombotics Don't Add Xarelto for Most Coronary or Peripheral Artery Disease Patients
Hyponatremia Stay Alert for Meds That May Lead to Low Sodium Levels
Raynaud's Know Which Meds Worsen or Improve Raynaud's Phenomenon
Aspirin Don't Recommend Aspirin to Prevent Cancer
Pediatrics Be Prepared to Treat Croup
Supplements Be Ready for Questions About the Activated Charcoal "Health" Trend
Migraine Don't Jump to a CGRP Antagonist for Migraine Prophylaxis
Biosimilars Address Confusion About Biosimilars

Don't Jump to a CGRP Antagonist for Migraine Prophylaxis

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Table of Contents